Otsuka Pharmaceutical Companies (U.S.) 在哪里?
Otsuka Pharmaceutical Companies (U.S.) 的总部位于 508 Carnegie Center, Princeton, NJ 08540, US
Otsuka Pharmaceutical Companies (U.S.) 的电话号码是多少?
Otsuka Pharmaceutical Companies (U.S.) 的电话号码是 +1 609-853-2040
Otsuka Pharmaceutical Companies (U.S.) 的官方网站是什么?
Otsuka Pharmaceutical Companies (U.S.) 的公司官方网站是 http://www.otsuka-us.com
Otsuka Pharmaceutical Companies (U.S.) 是做什么的?
Otsuka is a healthcare company driven by our purpose and defined by our beliefs.
Otsuka Pharmaceutical Companies (U.S.) 的业务有哪些?
neuroscience,cardiovascular,oncology,medical devices
Otsuka Pharmaceutical Companies (U.S.) 的年收入是多少?
Otsuka Pharmaceutical Companies (U.S.) 的收入是 118000000美元
Otsuka Pharmaceutical Companies (U.S.) 有多少员工?
Otsuka Pharmaceutical Companies (U.S.) 有 5700 名员工
Otsuka Pharmaceutical Companies (U.S.) 属于哪个行业?
Otsuka Pharmaceutical Companies (U.S.) 从事以下行业: pharmaceuticals
Otsuka Pharmaceutical Companies (U.S.) 使用什么技术?
Otsuka Pharmaceutical Companies (U.S.) 使用的一些流行技术包括: Acquia Cloud,Adform,Adobe Marketing Cloud,Adobe Media Optimizer,Amazon AWS,Amazon SES,Atlassian Cloud,Bootstrap Framework,GitHub Hosting,Google Tag Manager,Linkedin Marketing Solutions,Microsoft Office 365,Mobile Friendly,NSOne,New Relic,Nginx,OneTrust,Outlook,React Redux,Remote,Twitter Advertising,Varnish,Vimeo,Workday Recruit,Zencoder,reCAPTCHA
如何联系 Otsuka Pharmaceutical Companies (U.S.)?
Otsuka Pharmaceutical Companies (U.S.) 联系信息:
电话号码:+1 609-853-2040,
网站:http://www.otsuka-us.com,
邮箱:ema***@***.com
Otsuka Pharmaceutical Companies (U.S.) 的社交媒体链接是什么?
Otsuka Pharmaceutical Companies (U.S.) 领英:http://www.linkedin.com/company/otsuka-pharmaceutical-companies,fackbook:https://facebook.com/Avanir-Pharmaceuticals-302303423181237/,twitte:https://twitter.com/otsukaus
Otsuka Pharmaceutical Companies (U.S.) 是一家上市公司吗?
是的,Otsuka Pharmaceutical Companies (U.S.)是一家上市公司,在nasdaq公开挂牌上市,上市交易代码:AVNR
Otsuka Pharmaceutical Companies (U.S.) 的最后一轮融资是什么时候?
暂无最近投资信息
谁投资 Otsuka Pharmaceutical Companies (U.S.)?
Otsuka Pharmaceutical Companies (U.S.) 有 0 家投资者,包括 。